Activating dormant strongyloidiasis secondary to COVID-19 treatment
<p>The SARS-CoV-2 pandemic has grown into a major global concern with huge efforts to combat the spread. Exaggerated inflammatory response plays a major role in which was the rationale to use corticosteroids to treat patients. However, multiple studies showed an association between opportunist...
Saved in:
Main Authors: | Fahad Alkaabba (Author), Holman Li (Author), Farrah Ibrahim (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Medical and Clinical Case Reports - Peertechz Publications,
2022-02-01.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
La belle (au bois) dormant
by: López Mozo, Jerónimo
Published: (2018) -
White lesion: A dormant malignancy?
by: Vela D Desai, et al.
Published: (2014) -
Dormant Account Reactivation at Al-Shajar Capital
by: Muhammad Yawar Uz Zaman, et al.
Published: (2019) -
Is strongyloidiasis endemic in Spain?
by: Angela Martinez-Perez, et al.
Published: (2015) -
Strongyloidiasis in the immunocompetent: an overlooked infection
by: Niranjan Tachamo, et al.
Published: (2016)